Jacobs Levy Equity Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,258,561
| Closed | -$4.19M | – | 1102 |
|
|
2025
Q1 | $4.19M | Buy |
+1,258,561
| New | +$4.19M | 0.02% | 502 |
|
|
2023
Q3 | – | Sell |
-515,035
| Closed | -$3.63M | – | 1010 |
|
|
2023
Q2 | $3.63M | Sell |
515,035
-1,045,893
| -67% | -$7.36M | 0.02% | 464 |
|
|
2023
Q1 | $9.54M | Buy |
1,560,928
+1,099,468
| +238% | +$6.72M | 0.06% | 293 |
|
|
2022
Q4 | $2.95M | Buy |
461,460
+276,063
| +149% | +$1.76M | 0.02% | 480 |
|
|
2022
Q3 | $1.78M | Buy |
185,397
+14,743
| +9% | +$141K | 0.01% | 583 |
|
|
2022
Q2 | $1.88M | Buy |
+170,654
| New | +$1.88M | 0.01% | 613 |
|